IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia

Clinical trial NCT07257640 · RECRUITING

Trial details

NCT number: NCT07257640
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Diseases Neoplasms

Start date: 2025-11-30
Primary completion: 2028-11-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.